BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22495310)

  • 1. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes.
    Wang Y; Li G; Goode J; Paz JC; Ouyang K; Screaton R; Fischer WH; Chen J; Tabas I; Montminy M
    Nature; 2012 Apr; 485(7396):128-32. PubMed ID: 22495310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRTC2 Is a Coactivator of GR and Couples GR and CREB in the Regulation of Hepatic Gluconeogenesis.
    Hill MJ; Suzuki S; Segars JH; Kino T
    Mol Endocrinol; 2016 Jan; 30(1):104-17. PubMed ID: 26652733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide enhanced the hepatic glucagon response through regulation of CREB activity.
    Wang J; Wang D; Lu S; Hu Y; Ge Y; Qin X; Mo Y; Kan J; Li D; Zhang R; Liu Y; Zhang WS
    Clin Nutr; 2024 Feb; 43(2):366-378. PubMed ID: 38142481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism.
    Xue Y; Cui A; Wei S; Ma F; Liu Z; Fang X; Huo S; Sun X; Li W; Hu Z; Liu Y; Cai G; Su W; Zhao J; Yan X; Gao C; Wen J; Zhang H; Li H; Liu Y; Lin X; Xu Y; Fu W; Fang J; Li Y
    Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2219419120. PubMed ID: 37252972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon receptor-mediated regulation of gluconeogenic gene transcription is endocytosis-dependent in primary hepatocytes.
    Cajulao JMB; Hernandez E; von Zastrow ME; Sanchez EL
    Mol Biol Cell; 2022 Sep; 33(10):ar90. PubMed ID: 35767325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection.
    Karanth S; Chaurasia B; Bowman FM; Tippetts TS; Holland WL; Summers SA; Schlegel A
    Physiol Rep; 2019 Sep; 7(18):e14238. PubMed ID: 31552709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi screening in primary human hepatocytes of genes implicated in genome-wide association studies for roles in type 2 diabetes identifies roles for CAMK1D and CDKAL1, among others, in hepatic glucose regulation.
    Haney S; Zhao J; Tiwari S; Eng K; Guey LT; Tien E
    PLoS One; 2013; 8(6):e64946. PubMed ID: 23840313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Hepatic Lipid and Glucose Metabolism by INSP3R1.
    Perry RJ
    Diabetes; 2022 Sep; 71(9):1834-1841. PubMed ID: 35657697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states.
    Xu S; Liu Y; Hu R; Wang M; Stöhr O; Xiong Y; Chen L; Kang H; Zheng L; Cai S; He L; Wang C; Copps KD; White MF; Miao J
    Elife; 2021 Oct; 10():. PubMed ID: 34622775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominin-1-Radixin axis controls hepatic gluconeogenesis by regulating PKA activity.
    Lee H; Yu DM; Park JS; Lee H; Kim JS; Kim HL; Koo SH; Lee JS; Lee S; Ko YG
    EMBO Rep; 2020 Nov; 21(11):e49416. PubMed ID: 33030802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial hepatocyte plasticity of gluconeogenesis during the metabolic transitions between fed, fasted and starvation states.
    Okada J; Landgraf A; Xiaoli AM; Liu L; Horton M; Schuster VL; Yang F; Sidoli S; Qiu Y; Kurland IJ; Eliscovich C; Shinoda K; Pessin JE
    bioRxiv; 2024 Apr; ():. PubMed ID: 38746329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal multiscale modeling of biochemical regulatory networks: Calcium-regulated hepatocyte lipid and glucose metabolism.
    Martyshina AV; Sirotkina AG; Gosteva IV
    Biosystems; 2024 Jun; 240():105227. PubMed ID: 38718915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin-mediated dephosphorylation enhances the stability and transactivation of c-Myc.
    Masaki T; Habara M; Hanaki S; Sato Y; Tomiyasu H; Miki Y; Shimada M
    Sci Rep; 2023 Aug; 13(1):13116. PubMed ID: 37573463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation-enhanced CRTC2 expression drives malignant phenotypes and primary resistance to immunotherapy in hepatocellular carcinoma.
    Zhang R; Dai J; Yao F; Zhou S; Huang W; Xu J; Yu K; Chen Y; Fan B; Zhang L; Xu J; Li Q
    iScience; 2024 Jun; 27(6):109821. PubMed ID: 38770131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon regulates lipolysis and fatty acid oxidation through inositol triphosphate receptor 1 in the liver.
    Hayashi Y
    J Diabetes Investig; 2021 Jan; 12(1):32-34. PubMed ID: 32506830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperpolarized Dihydroxyacetone Is a Sensitive Probe of Hepatic Gluconeogenic State.
    Ragavan M; McLeod MA; Giacalone AG; Merritt ME
    Metabolites; 2021 Jul; 11(7):. PubMed ID: 34357335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.
    Ozcan L; Wong CC; Li G; Xu T; Pajvani U; Park SK; Wronska A; Chen BX; Marks AR; Fukamizu A; Backs J; Singer HA; Yates JR; Accili D; Tabas I
    Cell Metab; 2012 May; 15(5):739-51. PubMed ID: 22503562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver.
    Patel K; Foretz M; Marion A; Campbell DG; Gourlay R; Boudaba N; Tournier E; Titchenell P; Peggie M; Deak M; Wan M; Kaestner KH; Göransson O; Viollet B; Gray NS; Birnbaum MJ; Sutherland C; Sakamoto K
    Nat Commun; 2014 Aug; 5():4535. PubMed ID: 25088745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects.
    Ravnskjaer K; Hogan MF; Lackey D; Tora L; Dent SY; Olefsky J; Montminy M
    J Clin Invest; 2013 Oct; 123(10):4318-28. PubMed ID: 24051374
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.